IP Library Granted Patent US 10,928,390
Granted Patent B2
US 10,928,390 · App. 16/192,432 · Granted Feb 23, 2021

Medical apparatus for testing for medical conditions including zika and pregnancy

Inventors: Jovan Hutton Pulitzer (Frisco, TX); Henry Joseph Legere, III (Austin, TX)
Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
G01N33/558G01N15/0612G01N33/54366G01N33/56983G01N33/689G01N33/6893G01N33/76G06K9/3216G06T7/0012G06T7/0014G06T7/33G06T2207/10024G06T2207/30072Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,928,390
App. No.
16/192,432
Granted
Feb 23, 2021
Kind
B2
Abstract

A system for providing immunoassay test results for multiple medical conditions, comprising a testing device having thereon an alignment target and having a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a sample pad capable of receiving a biologic sample, a conjugate pad containing particles for conjugating with antibodies or antigens present in the biologic sample, and a membrane strip having a test line and a control line, wherein the test line and the control line are viewable, and a mobile device having a camera, a viewing screen, and a software application stored thereon, wherein the software application provides executable instructions to capture an image of the testing device, process an image to determine pixel count and line intensity of the test line of each of the plurality of immunoassay test strips, and present test results on the viewing screen.

Claims (25)

1. A testing apparatus, comprising,

a housing;

one or more biologic sample wells disposed in a surface of the housing for receiving a biologic sample;

a plurality of test strips secured to the housing, each disposed below one of the one or more biologic sample wells, and each one of the plurality of test strips including:

a viewable surface;

a test region including test strip specific antigens or antibodies;

a control region including test strip specific control antigens or antibodies;

a membrane connecting one of the one or more biologic sample wells to the test region and to the control region such that the biologic sample is first wicked to the test region and then to the control region, thus conveying antigens or antibodies in the test region to the control region;

the plurality of test strips secured adjacent to each other;

a first one of the plurality of test strips including Zika virus antigen in the test region of the first one of the plurality of test strips; and

a second one of the plurality of test strips including an antibody suitable for binding with hCG in the test region of the second one of the plurality of test strips.

2. The testing apparatus of claim 1 , wherein the first one of the plurality of test strips and the second one of the plurality of test strips are oriented in a same direction.

3. The testing apparatus of claim 1 , wherein the one or more biologic sample wells are disposed at one end of the housing.

4. The testing apparatus of claim 1 , wherein the testing apparatus is associated with a single user.

5. The testing apparatus of claim 4 , wherein the single user deposits the biologic sample within the one or more biologic sample wells to apply the biologic sample to at least the first one of the plurality of test strips and the second one of the plurality of test strips at substantially a same time.

6. The testing apparatus of claim 1 , further comprising a wall disposed within the housing, wherein the wall separates at least the first one of the plurality of test strips and the second one of the plurality of test strips from each other.

7. The testing apparatus of claim 1 , wherein each one of the plurality of test strips further include a sample pad capable of receiving the biologic sample deposited in the one or more biologic sample wells.

8. The testing apparatus of claim 7 , wherein each one of the plurality of test strips further includes a conjugate pad including particles for conjugating with antibodies or antigens present in the biologic sample.

9. The testing apparatus of claim 8 , wherein the conjugate pad includes gold particles.

10. The testing apparatus of claim 1 , further comprising one or more windows disposed on the housing.

11. The testing apparatus of claim 10 , wherein each of the one or more windows is associated with one of the plurality of test strips.

12. The testing apparatus of claim 11 , wherein the test region and the control region of each one of the plurality of test strips are viewable through the associated one or more windows.

13. The testing apparatus of claim 1 , further comprising an alignment target disposed on the surface of the housing.

14. The testing apparatus of claim 13 , wherein the alignment target triggers a mobile device to capture an image of the testing apparatus.

15. The testing apparatus of claim 1 , wherein a test line of each of the plurality of test strips each provides test results indicating a positive or negative result.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2018
From: PULITZER, JOVAN HUTTON; LEGERE, HENRY JOSEPH, III
To: RELIANT IMMUNE DIAGNOSTICS, LLC
Reel/Frame 047518/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2018
From: RELIANT IMMUNE DIAGNOSTICS, LLC
To: RELIANT IMMUNE DIAGNOSTICS, INC.
Reel/Frame 047518/0647 →
Continuity (4)
Continuation 15786139 · Oct 17, 2017
Continuation 15295353 · Oct 17, 2016
Provisional Application 62409077 · Oct 17, 2016
Related Publication 20190086407A1 · Mar 21, 2019